HTC75, 293T and U2OS cells were cultured in DMEM with 10% fetal bovine serum. 293T was used to package virus and HTC75 was used to construct stable cell lines. TPP1ΔOBRD (∆T), truncated 1–330 amino acids of human TPP1, was cloned into phage-based tet-on lentiviral vector which have a C-terminal HA-flag tag and G418 resistance. TPP1 mutant overexpressed with 100 ng/ml DOX treatment. The target sequences of ATRX shRNA1 (sh590, shATRX-1) and ATRX shRNA2 (sh592, shATRX-2) were previously reported33 and were cloned into pCl-mU6 retroviral vectors with puromycin resistance. The target sequences of shGFP and DAXX shRNA1/2 (shDAXX-1 and shDAXX-2) were previously reported and were cloned into pCl-H1 lentiviral vectors using blasticidin (BSD)35. The sequences of shRNAs are:
ATRX shRNA1: CGACAGAAACTAACCCTGTAA
ATRX shRNA2: CCGGTGGTGAACATAAGAAAT
shGFP:5′-CACAAGCTGGAGTACAACT-3′
DAXX shRNA1: 5′-AAGGAGTTGGATCTCTCAGAA-3′
DAXX shRNA2: 5′-GGTAAAGATGGAGACAAGA-3′
The knockout cell lines were established using a transient transfection system (PX330 vectors) with guide RNA targeting DAXX or TERT51.
The gRNA sequences are:
DAXX: GATGTTGCAGAACTCCGCCG AGG
hTERT: GGCAGTCAGCGTCGTCCCC GGG
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.